Black Diamond Therapeutic...

NASDAQ: BDTX · Real-Time Price · USD
2.76
-0.03 (-1.08%)
At close: Aug 15, 2025, 3:59 PM
2.77
0.36%
After-hours: Aug 15, 2025, 06:01 PM EDT

Black Diamond Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
36.44M 56.22M 34.31M 65.8M
Short-Term Investments
62.14M 75.18M 88.49M 143.99M
Long-Term Investments
n/a n/a 1.17M 1.22M
Other Long-Term Assets
1.07M 823K n/a 5.93M
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
2.6M 2.63M 4.9M n/a
Total Current Assets
101.18M 134.03M 127.71M 209.79M
Property-Plant & Equipment
20.4M 23.71M 27.38M 30.74M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
21.46M 24.53M 28.55M 37.9M
Total Assets
122.64M 158.57M 156.25M 247.68M
Account Payables
4.01M 2.32M 1.88M 4.11M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
16.57M n/a n/a n/a
Total Current Liabilities
20.57M 19.65M 15.26M 23.64M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
18.78M 22.18M 25.3M 28.14M
Total Liabilities
39.35M 41.83M 40.56M 491.5M
Total Debt
22.19M 25.3M 28.14M 28.46M
Common Stock
7K 7K 5K 5K
Retained Earnings
-487.11M -417.43M -334.99M -243.82M
Comprehensive Income
24K -27K -1.82M -414K
Shareholders Equity
83.28M 116.74M -334.99M -243.82M
Total Investments
62.14M 75.18M 88.49M 143.99M